BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 35466932)

  • 1. Modified contrast-enhanced ultrasonography with the new high-resolution examination technique of high frame rate contrast-enhanced ultrasound (HiFR-CEUS) for characterization of liver lesions: First results.
    Jung EM; Moran VO; Engel M; Krüger-Genge A; Stroszczynski C; Jung F
    Clin Hemorheol Microcirc; 2023; 83(1):31-46. PubMed ID: 35466932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frame-rate contrast enhanced ultrasound (HIFR-CEUS) in the characterization of small hepatic lesions in cirrhotic patients.
    Giangregorio F; Garolfi M; Mosconi E; Ricevuti L; Debellis MG; Mendozza M; Esposito C; Vigotti E; Cadei D; Abruzzese D
    J Ultrasound; 2023 Mar; 26(1):71-79. PubMed ID: 36227456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
    Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
    Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
    Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
    Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of limited examination conditions on contrast-enhanced sonography for characterising liver lesions.
    Putz FJ; Verloh N; Erlmeier A; Schelker RC; Schreyer AG; Hautmann MG; Stroszczynski C; Banas B; Jung EM
    Clin Hemorheol Microcirc; 2019; 71(2):267-276. PubMed ID: 30584135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology.
    Huf S; Platz Batista da Silva N; Wiesinger I; Hornung M; Scherer MN; Lang S; Stroszczynski C; Fischer T; Jung EM
    Rofo; 2017 May; 189(5):431-440. PubMed ID: 28449169
    [No Abstract]   [Full Text] [Related]  

  • 13. Value of contrast-enhanced ultrasound (CEUS) in Focal Liver Lesions (FLL) with inconclusive findings on cross-sectional imaging.
    Auer TA; Fischer T; Garcia SRM; Penzkofer T; Jung EM; Hamm B; Lerchbaumer MH
    Clin Hemorheol Microcirc; 2020; 74(3):327-339. PubMed ID: 31658052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases.
    Sawatzki M; Güller U; Güsewell S; Husarik DB; Semela D; Brand S
    J Hepatol; 2021 Feb; 74(2):419-427. PubMed ID: 33065168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast enhanced ultrasound (CEUS) with parametric imaging and time intensity curve analysis (TIC) for evaluation of the success of prostate arterial embolization (PAE) in cases of prostate hyperplasia.
    Jung EM; Wertheimer T; Putz FJ; Jung F; Kammerer S; Pregler B; Luerken L; Stroszczynski C; Beyer L
    Clin Hemorheol Microcirc; 2020; 76(2):143-153. PubMed ID: 32925006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
    Zhang XY; Luo Y; Wen TF; Jiang L; Li C; Zhong XF; Zhang JY; Ling WW; Yan LN; Zeng Y; Wu H
    World J Gastroenterol; 2014 Sep; 20(35):12628-36. PubMed ID: 25253968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
    Schaible J; Stroszczynski C; Beyer LP; Jung EM
    Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 20. Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
    Fraquelli M; Nadarevic T; Colli A; Manzotti C; Giljaca V; Miletic D; Štimac D; Casazza G
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013483. PubMed ID: 36053210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.